Clark Estates Inc’s Medifast MED Stock Holding History

Clark Estates Inc’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-17,900	Closed	-$1.86M	–	97
2023 Q1	$1.86M	Sell	17,900 -4,000	-18%	-$443K	0.37%	82
2022 Q4	$2.53M	Hold	21,900	–	–	0.52%	70
2022 Q3	$2.37M	Hold	21,900	–	–	0.52%	70
2022 Q2	$3.95M	Buy	21,900 +7,200	+49%	+$1.29M	0.68%	43
2022 Q1	$2.51M	Buy	+14,700	New	+$2.77M	0.4%	80
2014 Q3	–	Sell	-45,000	Closed	-$1.37M	–	127
2014 Q2	$1.37M	Hold	45,000	–	–	0.2%	94
2014 Q1	$1.31M	Hold	45,000	–	–	0.2%	92
2013 Q4	$1.18M	Hold	45,000	–	–	0.17%	98
2013 Q3	$1.21M	Hold	45,000	–	–	0.18%	93
2013 Q2	$1.16M	Buy	+45,000	New	+$1.18M	0.2%	90

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Clark Estates Inc's MED Position: Q2 2023 in Review

Clark Estates Inc sold out of Medifast (MED) in Q2 2023, closing a stake of 17,900 shares — an estimated $1.86M sold.

Clark Estates Inc first reported a position in MED in Q2 2013 and held it in 10 quarters. The position peaked at $3.95M in Q2 2022. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.

Clark Estates Inc reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
Clark Estates Inc sold 17,900 Medifast shares in Q2 2023, an estimated $1.86M.
Clark Estates Inc first reported a position in Medifast in Q2 2013 and held it in 10 quarters.
Clark Estates Inc's Medifast position peaked at $3.95M in Q2 2022.
236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.

Based on Clark Estates Inc's 13F filing for Q2 2023, filed 11 Aug 2023.